Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Lorcaserin in Healthy Japanese Adults
NCT02192515Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lorcaserin in obesity (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Safety as assessed by adverse events (AEs), clinical laboratory tests, vital signs, body weight and ECGs, Pharmacokinetics of APD356: Cmax and 3 more. Started Jul 2014; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02192515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192515.